StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MeiraGTx's enterprise value was $868.78M on Nov 11, 2026, against $650.88M a year earlier. Over the last 5 years it ranged from $206.14M to $1.26B, with a median of $411.51M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$868.78M+39.5%
2025Dec 31, 2025$622.71M+47.9%
2024Dec 31, 2024$421.08M-1.1%
2023Dec 29, 2023$425.81M+71.9%
2022Dec 30, 2022$247.65M-72.7%
2021Dec 31, 2021$908.44M+125.9%
2020Dec 31, 2020$402.23M-16.0%
2019Dec 31, 2019$478.71M+176.1%
2018Dec 31, 2018$173.37M–

More MeiraGTx figures

See a number that looks wrong?